About Us
At SynBio Therapeutics We Are The Pharma Company of the Future.
The Pharma Company of the Future
Our mission is to bring new treatments to patients faster and more efficiently. We are a tech-driven, AI-native pharmaceutical and biotech company changing the way drug development is done.
Our Mission
Despite tech advancements, bringing a new drug to market remains a decade-long, billion-dollar endeavor. The time and costs of drug development continue to climb, leading to higher drug and healthcare costs, and making treatments less accessible for many. Our Pharmaceutical Sales Rep team can bring our model creates a radically more efficient approach across the drug distribution channels which ultimately bring pharmaceutical and biotech products faster than ever before so to bring treatments to patients.
Closing the gap between disease and treatment.
Purpose at SynBio Therapeutics
There are several thousand known human diseases, yet we only have FDA-approved pharmaceutical and biotech treatments for about 500 of them. Patients are desperately waiting for more. We are building the pharma company of the future designed to bring new treatments to patients faster than ever before.
Despite the sweeping technological changes transforming biotech — and society at large — the process of bringing a new drug to market still lasts longer than 10 years, and costs billions of dollars. What’s more, the time and costs are actually increasing, contributing to rising drug prices, inflated healthcare costs, and, ultimately, decreased access to treatments for patients.
The bottleneck isn’t discovery—it’s development.
Finding new drug candidates isn’t the problem
This was a fact I didn’t fully appreciate as a graduate student in computational biology. I initially believed that the availability of new treatments was limited because there simply weren’t enough drug candidates being researched and discovered. When I began my studies, I was excited about the potential for sequencing, big data, and artificial intelligence to revolutionize the pace of drug discovery.
What I came to recognize is that the industry is not lacking in promising drug candidates — it has plenty of them sitting idly at the top of the drug development funnel. In fact, if we were to stop research today, there are as many as 10 drug candidates for every one drug that makes it to trial. As technological advancements make drug discovery more efficient, this pile-up of possible new drugs is only going to get worse.
In order to bring treatments to patients faster, the most important bottleneck to fix is actually the one caused by the high costs and long durations of clinical development – the period spanning multiple phases of clinical trials that is required for every drug. Only a small handful of promising drugs candidates are currently making it through the development process. That must change in order to increase the total number of treatments available to patients.
Closing the gap between disease and treatment.
Building a mission-first company
Our mission defines our roadmap and clarifies our purpose. We strive to bring new treatments to patients faster and more efficiently because each and every one of us has family members or friends whose lives are affected by disease.
This is why we are driving so tirelessly towards our mission. Our team knows that time is of the essence — not just because a drug loses up to $5M in net present value each day it remains unavailable — but because a single day can make all the difference to a patient waiting for a life-saving treatment.
A mission as ambitious as ours can only be realized by a strong team of people, empowered to contribute their unique insights and ideas to help solve the problems we will face. We believe our success will be most influenced by the people we can attract to our cause and the values that we promote across our organization and with our partners. Our teams are formed by diverse, exceptional talent from across a myriad industries, merging tech with traditional pharma and beyond.
We believe the companies that stand the test are ones that put mission and purpose ahead of ego. They interrogate decisions based on first principles and understand that an ambitious, uncompromising roadmap can only be achieved through a sequence of deliberate and well-executed steps.
These companies understand that the accomplishments of yesteryear have little bearing on future success. They know that they’re only as great as their next hire, their next day, their next quarter, and their next year. This is the template to which our team aspires.
Let’s build the pharma company of the future
At the end of the day, we will judge our success by the impact we have on the lives of patients and how many new treatments we ultimately contribute to the world.
We are still in the early stages, but we’re so excited for what’s in store. If our values and mission speak to you, we welcome you to join us on this journey. Together, we can build the pharma company of the future.